marketcaparena
Search

    FLGT

    Fulgent Genetics, Inc.

    Company overview

    Market capitalization
    $615.24M
    Employees
    1,315
    Latest publication
    2026-09-29
    About Fulgent Genetics, Inc.

    Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, large corporations, and patients. Fulgent Genetics, Inc. was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The company was founded in 2011 and is headquartered in El Monte, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ3 20232023-09-30 · USDQ3 20222022-09-30 · USDQ2 20222022-06-30 · USDQ1 20222022-03-31 · USDQ4 20212021-12-31 · USDQ3 20212021-09-30 · USDQ2 20212021-06-30 · USD
    Total Revenue85,389,000USD84,687,000USD105,655,000USD125,341,000USD320,268,000USD251,671,000USD227,868,000USD153,616,000USD
    Cost Of Revenue59,710,000USD44,843,000USD59,560,000USD60,065,000USD77,725,000USD62,134,000USD43,466,000USD35,858,000USD
    Gross Profit25,679,000USD39,844,000USD46,095,000USD65,276,000USD242,543,000USD189,537,000USD184,402,000USD117,758,000USD
    Research Development14,554,000USD10,014,000USD7,507,000USD6,905,000USD5,989,000USD7,464,000USD6,021,000USD5,312,000USD
    Selling And Marketing Expenses15,228,000USD10,161,000USD9,859,000USD10,866,000USD7,940,000USD8,200,000USD6,012,000USD5,219,000USD
    General And Administrative Expenses27,195,000USD———————
    Other Operating Expenses2,603,000USD———————
    Total Operating Expenses61,752,000USD39,630,000USD45,743,000USD52,482,000USD40,610,000USD38,677,000USD25,129,000USD18,860,000USD
    Operating Income-36,073,000USD214,000USD352,000USD12,794,000USD201,933,000USD150,860,000USD159,273,000USD98,898,000USD
    Total Other Income Expense Net6,383,000USD6,646,000USD1,405,000USD958,000USD45,000USD-35,000USD496,000USD4,338,000USD
    Interest Income6,404,000USD6,646,000USD1,405,000USD958,000USD45,000USD35,000USD496,000USD604,000USD
    Interest Expense59,000USD70,000USD180,000USD958,000USD45,000USD35,000USD496,000USD604,000USD
    Income Before Tax-29,690,000USD6,860,000USD1,757,000USD13,752,000USD201,978,000USD150,825,000USD159,769,000USD103,236,000USD
    Income Tax Expense29,000USD20,326,000USD414,000USD2,653,000USD48,421,000USD47,148,000USD37,545,000USD23,589,000USD
    Net Income-29,719,000USD-13,107,000USD1,719,000USD11,537,000USD153,979,000USD104,339,000USD122,522,000USD79,812,000USD
    Minority Interest-189,000USD359,000USD-376,000USD-438,000USD-422,000USD662,000USD-298,000USD7,996,000USD
    Selling General Administrative—17,498,000USD26,266,000USD30,240,000USD25,775,000USD22,102,000USD12,299,000USD8,329,000USD
    Unclassified Operating Expenses—1,957,000USD2,111,000USD4,471,000USD————
    Net Interest Income—6,646,000USD1,405,000USD958,000USD45,000USD-35,000USD496,000USD604,000USD
    Tax Provision—20,326,000USD414,000USD2,653,000USD48,421,000USD47,148,000USD37,545,000USD23,589,000USD
    Net Income From Continuing Ops—-13,466,000USD1,343,000USD11,099,000USD153,557,000USD103,677,000USD122,224,000USD79,647,000USD
    Ebit—6,930,000USD457,000USD15,690,000USD201,978,000USD150,825,000USD159,769,000USD103,236,000USD
    Ebitda—13,349,000USD10,277,000USD24,035,000USD206,673,000USD154,788,000USD162,942,000USD105,654,000USD
    Depreciation And Amortization—6,419,000USD9,820,000USD8,345,000USD4,695,000USD3,963,000USD3,173,000USD2,418,000USD
    Reconciled Depreciation—6,419,000USD9,820,000USD8,345,000USD906,000USD911,000USD3,173,000USD2,418,000USD
    Non Operating Income Net Other——1,405,000USD958,000USD45,000USD3,699,000USD496,000USD604,000USD
    Net Income Applicable To Common Shares——1,719,000USD11,537,000USD153,979,000USD104,339,000USD122,522,000USD79,812,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20192019-12-31 · USDFY 20162016-12-31 · USD
    Total Revenue32,528,000USD18,276,000USD
    Cost Of Revenue14,107,000USD6,721,000USD
    Gross Profit18,421,000USD11,555,000USD
    Research Development6,537,000USD3,558,000USD
    Selling General Administrative6,414,000USD4,609,000USD
    Selling And Marketing Expenses5,898,000USD2,469,000USD
    Total Operating Expenses18,849,000USD10,636,000USD
    Operating Income-428,000USD919,000USD
    Interest Income837,000USD5,386,000USD
    Interest Expense2,167,000USD5,387,000USD
    Net Interest Income837,000USD-5,386,000USD
    Income Before Tax409,000USD-4,468,000USD
    Income Tax Expense43,000USD920,000USD
    Tax Provision43,000USD920,000USD
    Net Income366,000USD-5,388,000USD
    Net Income From Continuing Ops-411,000USD-5,388,000USD
    Ebit-428,000USD919,000USD
    Ebitda1,679,000USD2,089,000USD
    Depreciation And Amortization2,107,000USD1,170,000USD
    Reconciled Depreciation2,107,000USD—
    Total Other Income Expense Net837,000USD-5,386,000USD
    Non Operating Income Net Other60,000USD-5,386,000USD
    Net Income Applicable To Common Shares-411,000USD-13,666,000USD
    Discontinued Operations—41,000USD
    SourceLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets1,089,223,000USD1,156,369,000USD1,213,525,000USD1,214,563,000USD1,199,838,000USD1,205,744,000USD1,219,964,000USD1,233,763,000USD
    Cash And Equivalents26,305,000USD———————
    Total Current Assets454,770,000USD479,042,000USD550,490,000USD507,374,000USD428,727,000USD416,784,000USD353,571,000USD326,539,000USD
    Other Current Assets22,231,000USD126,234,000USD112,199,000USD42,792,000USD41,784,000USD7,403,000USD10,051,000USD39,943,000USD
    Other Non Current Assets23,949,000USD———————
    Total Liabilities93,237,000USD———————
    Total Current Liabilities71,756,000USD90,134,000USD84,967,000USD72,426,000USD71,335,000USD65,915,000USD72,899,000USD73,990,000USD
    Other Current Liabilities23,507,000USD———————
    Other Non Current Liabilities8,972,000USD———————
    Total Stockholder Equity1,001,619,000USD1,049,809,000USD1,111,989,000USD1,125,888,000USD1,116,580,000USD1,127,178,000USD1,133,228,000USD1,138,445,000USD
    Total Equity Including Noncontrolling Interest995,986,000USD———————
    Deferred Revenue3,404,000USD———————
    Net Receivables64,938,000USD75,736,000USD91,610,000USD78,715,000USD85,035,000USD80,440,000USD77,030,000USD64,895,000USD
    Property Plant Equipment Net113,068,000USD124,031,000USD112,549,000USD111,865,000USD110,223,000USD107,077,000USD105,549,000USD106,810,000USD
    Goodwill53,861,000USD———————
    Intangible Assets80,769,000USD153,989,000USD133,281,000USD135,255,000USD131,060,000USD133,009,000USD134,978,000USD137,115,000USD
    Accounts Payable15,555,000USD21,125,000USD18,654,000USD18,088,000USD18,887,000USD18,238,000USD18,364,000USD19,805,000USD
    Common Stock4,000USD4,000USD3,000USD3,000USD3,000USD3,000USD3,000USD3,000USD
    Retained Earnings475,598,000USD505,128,000USD529,954,000USD553,372,000USD559,980,000USD578,937,000USD590,467,000USD596,355,000USD
    Accumulated Other Comprehensive Income1,920,000USD4,536,000USD7,512,000USD6,823,000USD5,998,000USD4,335,000USD-368,000USD9,178,000USD
    Total Liab—112,215,000USD106,810,000USD93,806,000USD88,202,000USD82,974,000USD90,805,000USD98,865,000USD
    Other Current Liab—63,317,000USD-74,504,000USD21,523,000USD20,512,000USD15,359,000USD22,836,000USD22,381,000USD
    Capital Stock—4,000USD3,000USD3,000USD3,000USD3,000USD3,000USD3,000USD
    Good Will—53,731,000USD25,080,000USD25,080,000USD22,055,000USD22,055,000USD22,055,000USD22,055,000USD
    Cash—23,399,000USD50,193,000USD117,641,000USD87,880,000USD67,281,000USD55,144,000USD58,042,000USD
    Cash And Short Term Investments—276,302,000USD336,077,000USD375,803,000USD292,927,000USD320,321,000USD258,106,000USD213,069,000USD
    Current Deferred Revenue—3,007,000USD31,780,000USD30,852,000USD30,273,000USD30,512,000USD29,844,000USD29,911,000USD
    Net Debt—-13,230,000USD-42,516,000USD-110,098,000USD-80,494,000USD-59,624,000USD-46,676,000USD-48,994,000USD
    Short Term Debt—2,685,000USD1,938,000USD1,963,000USD1,663,000USD1,806,000USD1,855,000USD1,893,000USD
    Short Long Term Debt—482,000USD476,000USD476,000USD476,000USD476,000USD412,000USD412,000USD
    Short Long Term Debt Total—10,169,000USD7,677,000USD7,543,000USD7,386,000USD7,657,000USD8,468,000USD9,048,000USD
    Long Term Debt—1,476,000USD1,958,000USD1,958,000USD1,958,000USD1,958,000USD2,493,000USD2,493,000USD
    Long Term Investments—328,287,000USD369,269,000USD411,778,000USD484,471,000USD494,111,000USD570,351,000USD602,232,000USD
    Short Term Investments—252,903,000USD285,884,000USD258,162,000USD205,047,000USD253,040,000USD202,962,000USD155,027,000USD
    Inventory—770,000USD10,604,000USD10,064,000USD8,981,000USD8,620,000USD8,384,000USD8,632,000USD
    Property Plant Equipment Gross—177,653,000USD170,494,000USD166,064,000USD168,959,000USD161,945,000USD157,260,000USD155,923,000USD
    Common Stock Shares Outstanding—30,881,000shares30,777,000shares30,749,000shares30,832,000shares30,832,000shares30,652,000shares30,416,000shares
    Non Current Assets Total—677,327,000USD663,035,000USD707,189,000USD771,111,000USD788,960,000USD866,393,000USD907,224,000USD
    Non Current Liabilities Total—22,081,000USD21,843,000USD21,380,000USD16,867,000USD17,059,000USD17,906,000USD24,875,000USD
    Non Current Liabilities Other—7,615,000USD9,168,000USD8,760,000USD5,020,000USD4,971,000USD4,923,000USD10,986,000USD
    Non Currrent Assets Other—17,154,000USD22,856,000USD23,211,000USD23,302,000USD32,708,000USD33,460,000USD39,012,000USD
    Net Working Capital—388,908,000USD465,523,000USD434,948,000USD357,392,000USD350,869,000USD280,672,000USD252,549,000USD
    Unclassified Non Current Liabilities—12,990,000USD10,717,000USD10,662,000USD9,889,000USD10,130,000USD10,490,000USD11,396,000USD
    Unclassified Equity—540,137,000USD574,517,000USD565,687,000USD550,596,000USD543,900,000USD543,123,000USD532,906,000USD
    Unclassified Current Liabilities——32,119,000USD—————
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets1,213,525,000USD1,219,964,000USD1,235,328,000USD1,386,053,000USD1,278,720,000USD700,461,000USD88,756,000USD55,015,000USD
    Intangible Assets133,281,000USD134,978,000USD143,053,000USD150,643,000USD35,914,000USD———
    Other Current Assets112,199,000USD10,051,000USD20,419,000USD22,248,000USD5,960,000USD3,696,000USD1,334,000USD1,957,000USD
    Total Liab106,810,000USD90,805,000USD102,042,000USD116,178,000USD112,840,000USD131,074,000USD5,979,000USD2,745,000USD
    Total Stockholder Equity1,111,989,000USD1,133,228,000USD1,136,101,000USD1,266,685,000USD1,158,749,000USD569,387,000USD82,777,000USD52,270,000USD
    Other Current Liab-74,504,000USD22,836,000USD26,944,000USD24,150,000USD28,369,000USD8,261,000USD1,333,000USD1,425,000USD
    Common Stock3,000USD3,000USD3,000USD3,000USD3,000USD3,000USD2,000USD2,000USD
    Capital Stock3,000USD3,000USD3,000USD3,000USD3,000USD3,000USD2,000USD2,000USD
    Retained Earnings529,954,000USD590,467,000USD633,175,000USD801,000,000USD657,597,000USD150,881,000USD-63,429,000USD-63,018,000USD
    Good Will25,080,000USD22,055,000USD22,055,000USD143,027,000USD50,897,000USD0USD——
    Cash50,193,000USD55,144,000USD97,473,000USD79,506,000USD164,894,000USD87,426,000USD11,965,000USD6,736,000USD
    Cash And Short Term Investments336,077,000USD258,106,000USD424,154,000USD526,235,000USD450,499,000USD299,367,000USD28,269,000USD37,420,000USD
    Total Current Assets550,490,000USD353,571,000USD507,845,000USD627,873,000USD611,960,000USD523,616,000USD37,079,000USD43,374,000USD
    Total Current Liabilities84,967,000USD72,899,000USD73,018,000USD88,107,000USD105,310,000USD130,115,000USD3,723,000USD2,745,000USD
    Current Deferred Revenue31,780,000USD29,844,000USD25,574,000USD14,094,000USD34,376,000USD26,761,000USD365,000USD—
    Net Debt-42,516,000USD-46,676,000USD-82,222,000USD-40,569,000USD-143,610,000USD-71,572,000USD-9,289,000USD-6,736,000USD
    Short Term Debt1,938,000USD1,855,000USD5,140,000USD26,770,000USD21,284,000USD15,286,000USD420,000USD—
    Short Long Term Debt476,000USD412,000USD1,183,000USD20,638,000USD21,284,000USD15,019,000USD——
    Short Long Term Debt Total7,677,000USD8,468,000USD15,251,000USD38,937,000USD21,284,000USD15,854,000USD2,676,000USD—
    Long Term Debt1,958,000USD2,493,000USD2,964,000USD3,372,000USD————
    Long Term Investments369,269,000USD570,351,000USD444,009,000USD339,033,000USD507,012,000USD132,502,000USD42,819,000USD7,898,000USD
    Short Term Investments285,884,000USD202,962,000USD326,681,000USD446,729,000USD285,605,000USD211,941,000USD16,304,000USD30,684,000USD
    Net Receivables91,610,000USD77,030,000USD57,445,000USD75,110,000USD143,295,000USD204,062,000USD7,199,000USD6,238,000USD
    Inventory10,604,000USD8,384,000USD5,827,000USD4,280,000USD12,206,000USD16,491,000USD277,000USD314,000USD
    Accounts Payable18,654,000USD18,364,000USD15,360,000USD23,093,000USD20,494,000USD26,488,000USD1,581,000USD1,313,000USD
    Property Plant Equipment Net112,549,000USD105,549,000USD83,464,000USD81,353,000USD62,287,000USD40,199,000USD8,607,000USD6,446,000USD
    Property Plant Equipment Gross170,494,000USD157,260,000USD135,097,000USD124,634,000USD81,917,000USD41,027,000USD8,607,000USD6,446,000USD
    Accumulated Other Comprehensive Income7,512,000USD-368,000USD1,205,000USD-20,903,000USD-759,000USD438,000USD146,000USD-35,000USD
    Common Stock Shares Outstanding30,777,000shares30,235,000shares29,784,000shares30,964,000shares30,976,000shares24,056,000shares18,709,000shares17,978,000shares
    Non Current Assets Total663,035,000USD866,393,000USD727,483,000USD758,180,000USD666,760,000USD176,845,000USD51,677,000USD11,641,000USD
    Non Current Liabilities Total21,843,000USD17,906,000USD29,024,000USD28,071,000USD7,530,000USD959,000USD2,256,000USD14,000USD
    Non Current Liabilities Other9,168,000USD4,923,000USD10,951,000USD28,071,000USD7,530,000USD959,000USD2,256,000USD14,000USD
    Non Currrent Assets Other22,856,000USD33,460,000USD34,902,000USD44,124,000USD10,650,000USD4,144,000USD251,000USD-2,703,000USD
    Net Working Capital465,523,000USD280,672,000USD434,827,000USD539,766,000USD961,618,000USD393,501,000USD33,356,000USD36,805,000USD
    Unclassified Current Liabilities32,119,000USD—-1,183,000USD-20,638,000USD-20,497,000USD38,300,000USD——
    Unclassified Non Current Liabilities10,717,000USD10,490,000USD15,109,000USD-20,830,000USD————
    Unclassified Equity574,517,000USD543,123,000USD501,715,000USD486,582,000USD501,905,000USD418,062,000USD146,056,000USD115,319,000USD
    Other Assets——1USD26,556,000USD912,627,000USD44,536,000USD251,000USD17,000USD
    Other Liab———17,458,000USD788,000USD391,000USD—14,000USD
    Net Tangible Assets———973,015,000USD1,165,880,000USD569,387,000USD82,777,000USD51,152,000USD
    Unclassified Non Current Assets———-26,556,000USD-912,627,000USD-44,536,000USD—-2,720,000USD
    Unclassified Current Assets———————-2,555,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-24,826,000USD-23,650,000USD-6,826,000USD-19,256,000USD-11,899,000USD-6,190,000USD-14,694,000USD-9,090,000USD
    Depreciation6,000,000USD6,112,000USD6,038,000USD6,054,000USD5,919,000USD6,192,000USD5,920,000USD6,153,000USD
    Stock Based Compensation9,890,000USD9,276,000USD9,717,000USD10,039,000USD10,550,000USD10,408,000USD10,920,000USD11,635,000USD
    Other Non Cash Items10,284,000USD2,370,000USD495,000USD11,485,000USD786,000USD546,000USD10,424,000USD-1,690,000USD
    Change To Account Receivables16,431,000USD-15,377,000USD4,907,000USD-8,257,000USD-4,524,000USD-13,325,000USD-1,585,000USD-2,877,000USD
    Change In Working Capital16,759,000USD-71,710,000USD2,384,000USD-38,517,000USD-9,791,000USD16,188,000USD-25,752,000USD-2,583,000USD
    Total Cash From Operating Activities7,097,000USD-78,143,000USD11,107,000USD-30,171,000USD-4,431,000USD25,018,000USD-15,509,000USD4,285,000USD
    Capital Expenditures-5,202,000USD-4,980,000USD-6,050,000USD-6,826,000USD-4,718,000USD-3,778,000USD-19,537,000USD-12,944,000USD
    Free Cash Flow1,895,000USD-83,123,000USD5,057,000USD-36,997,000USD-9,149,000USD21,240,000USD-35,046,000USD-8,659,000USD
    Investments71,700,000USD16,134,000USD19,084,000USD53,404,000USD27,729,000USD-27,455,000USD8,985,000USD7,304,000USD
    Total Cashflows From Investing Activities10,939,000USD11,154,000USD19,084,000USD53,404,000USD27,729,000USD-27,455,000USD8,985,000USD7,304,000USD
    Net Borrowings-564,000USD-88,000USD-88,000USD-88,000USD-606,000USD-136,000USD-136,000USD—
    Total Cash From Financing Activities-44,833,000USD-534,000USD-445,000USD-2,638,000USD-11,172,000USD-327,000USD-567,000USD-1,146,000USD
    Sale Purchase Of Stock-40,078,000USD-447,000USD-357,000USD-2,550,000USD-10,566,000USD-242,000USD-431,000USD-544,000USD
    Change In Cash-26,794,000USD-67,448,000USD29,761,000USD20,599,000USD12,137,000USD-2,898,000USD-6,934,000USD10,434,000USD
    Begin Period Cash Flow50,193,000USD117,776,000USD88,015,000USD67,416,000USD55,279,000USD58,177,000USD65,111,000USD54,677,000USD
    End Period Cash Flow23,399,000USD50,328,000USD117,776,000USD88,015,000USD67,416,000USD55,279,000USD58,177,000USD65,111,000USD
    Other Cashflows From Investing Activities8,000USD-3,775,000USD3,778,000USD—2,000USD—38,000USD17,000USD
    Other Cashflows From Financing Activities-4,200,000USD1,000USD-445,000USD-345,000USD-11,172,000USD51,000USD8,985,000USD-544,000USD
    Unclassified Operating Cash Flow-11,010,000USD————-2,126,000USD-2,327,000USD—
    Unclassified Investing Cash Flow-55,567,000USD3,775,000USD2,272,000USD6,826,000USD4,716,000USD3,778,000USD19,499,000USD12,927,000USD
    Unclassified Financing Cash Flow————11,172,000USD—-8,985,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USD
    Net Income214,310,000USD-411,000USD-2,510,000USD-5,388,000USD
    Depreciation2,962,000USD2,520,000USD1,728,000USD1,170,000USD
    Stock Based Compensation8,157,000USD3,209,000USD2,119,000USD4,654,000USD
    Other Non Cash Items8,048,000USD4,344,000USD1,044,000USD5,580,000USD
    Change To Account Receivables-178,480,000USD-839,000USD214,000USD-2,322,000USD
    Change To Liabilities108,567,000USD-41,000USD-363,000USD1,094,000USD
    Change In Working Capital-91,451,000USD-915,000USD-714,000USD-1,857,000USD
    Total Cash From Operating Activities140,628,000USD5,517,000USD1,331,000USD4,405,000USD
    Capital Expenditures-36,510,000USD-1,182,000USD-5,356,000USD-3,788,000USD
    Free Cash Flow104,118,000USD4,335,000USD-4,025,000USD617,000USD
    Investments-289,936,000USD-27,864,000USD3,307,000USD-42,795,000USD
    Total Cashflows From Investing Activities-326,438,000USD-29,046,000USD-2,049,000USD-42,795,000USD
    Net Borrowings15,019,000USD15,019,000USD15,019,000USD—
    Total Cash From Financing Activities261,251,000USD28,775,000USD-770,000USD45,789,000USD
    Dividends Paid-15,019,000USD—0USD-4,592,000USD
    Sale Purchase Of Stock-62,000USD-21,000USD31,000USD-6,587,000USD
    Issuance Of Capital Stock246,190,000USD28,758,000USD——
    Change In Cash75,461,000USD5,229,000USD-1,407,000USD7,399,000USD
    Begin Period Cash Flow11,965,000USD6,736,000USD7,897,000USD498,000USD
    End Period Cash Flow87,426,000USD11,965,000USD6,490,000USD7,897,000USD
    Cash And Cash Equivalents Changes75,441,000USD5,246,000USD-1,407,000USD7,399,000USD
    Other Cashflows From Investing Activities8,000USD-137,000USD-2,461,000USD-39,007,000USD
    Other Cashflows From Financing Activities104,000USD17,000USD-770,000USD56,968,000USD
    Unclassified Financing Cash Flow261,209,000USD13,760,000USD-15,050,000USD—
    Unclassified Operating Cash Flow—-3,230,000USD——
    Change To Inventory——-30,492,000USD-23,451,000USD
    Exchange Rate Changes——81,000USD—
    Unclassified Investing Cash Flow——2,461,000USD42,795,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30SegmentLaboratory Services85,359,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentTherapeutic Development30,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31SegmentLaboratory Services71,051,000USD0001193125-26-199065
    Q1 2026Quarterly · 2026-03-31SegmentTherapeutic Development87,000USD0001193125-26-199065
    Q4 2025Quarterly · 2025-12-31SegmentLaboratory Services83,027,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentTherapeutic Development309,000USDLegacy provider
    FY 2025Yearly · 2025-12-31SegmentLaboratory Services322,224,000USD0001193125-26-079169
    FY 2025Yearly · 2025-12-31SegmentTherapeutic Development447,000USD0001193125-26-079169
    Q3 2025Quarterly · 2025-09-30SegmentLaboratory Services83,931,000USD0001193125-25-271013
    Q3 2025Quarterly · 2025-09-30SegmentTherapeutic Development138,000USD0001193125-25-271013
    Q2 2025Quarterly · 2025-06-30SegmentLaboratory Services81,803,000USD0000950170-25-101105
    Q2 2025Quarterly · 2025-06-30SegmentTherapeutic Development0USD0000950170-25-101105
    Q1 2025Quarterly · 2025-03-31SegmentLaboratory Services73,463,000USD0001193125-26-199065
    Q1 2025Quarterly · 2025-03-31SegmentTherapeutic Development0USD0001193125-26-199065
    Q4 2024Quarterly · 2024-12-31SegmentLaboratory Services76,214,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentTherapeutic Development0USDLegacy provider
    FY 2024Yearly · 2024-12-31SegmentLaboratory Services283,470,000USD0001193125-26-079169
    FY 2024Yearly · 2024-12-31SegmentTherapeutic Development0USD0001193125-26-079169
    Q3 2024Quarterly · 2024-09-30SegmentLaboratory Services71,743,000USD0001193125-25-271013
    Q3 2024Quarterly · 2024-09-30SegmentTherapeutic Development0USD0001193125-25-271013
    Q1 2024Quarterly · 2024-03-31GeographyChina4,104,000USD0000950170-24-052485
    Q1 2024Quarterly · 2024-03-31GeographyOther Countries2,531,000USD0000950170-24-052485
    Q1 2024Quarterly · 2024-03-31GeographyUnited States57,850,000USD0000950170-24-052485
    FY 2023Yearly · 2023-12-31SegmentLaboratory Services289,213,000USD0001193125-26-079169
    FY 2023Yearly · 2023-12-31SegmentTherapeutic Development0USD0001193125-26-079169
    Q4 2023Quarterly · 2023-12-31GeographyInternational5,615,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31GeographyUnited States64,890,000USDLegacy provider
    FY 2023Yearly · 2023-12-31GeographyInternational20,236,000USD0000950170-24-022233
    FY 2023Yearly · 2023-12-31GeographyUnited States268,977,000USD0000950170-24-022233
    Q3 2023Quarterly · 2023-09-30GeographyInternational5,713,000USD0000950170-23-058512
    Q3 2023Quarterly · 2023-09-30GeographyUnited States78,974,000USD0000950170-23-058512
    Q2 2023Quarterly · 2023-06-30GeographyInternational4,802,000USD0000950170-23-038316
    Q2 2023Quarterly · 2023-06-30GeographyUnited States63,051,000USD0000950170-23-038316
    Q1 2023Quarterly · 2023-03-31GeographyChina2,088,000USD0000950170-24-052485
    Q1 2023Quarterly · 2023-03-31GeographyOther Countries2,018,000USD0000950170-24-052485
    Q1 2023Quarterly · 2023-03-31GeographyUnited States62,062,000USD0000950170-24-052485
    FY 2022Yearly · 2022-12-31SegmentLaboratory Services618,968,000USD0000950170-25-029512
    FY 2022Yearly · 2022-12-31SegmentTherapeutic Development0USD0000950170-25-029512
    Q4 2022Quarterly · 2022-12-31GeographyInternational5,357,000USDLegacy provider
    Q4 2022Quarterly · 2022-12-31GeographyUnited States62,347,000USDLegacy provider
    FY 2022Yearly · 2022-12-31GeographyInternational15,820,000USD0000950170-24-022233
    FY 2022Yearly · 2022-12-31GeographyUnited States603,148,000USD0000950170-24-022233
    Q3 2022Quarterly · 2022-09-30GeographyInternational4,140,000USD0000950170-23-058512
    Q3 2022Quarterly · 2022-09-30GeographyUnited States101,515,000USD0000950170-23-058512
    Q2 2022Quarterly · 2022-06-30GeographyInternational3,245,000USD0000950170-23-038316
    Q2 2022Quarterly · 2022-06-30GeographyUnited States122,096,000USD0000950170-23-038316
    FY 2021Yearly · 2021-12-31SegmentLaboratory Services992,584,000USD0000950170-24-022233
    FY 2021Yearly · 2021-12-31SegmentTherapeutic Development0USD0000950170-24-022233
    FY 2021Yearly · 2021-12-31GeographyInternational13,606,000USD0000950170-24-022233
    FY 2021Yearly · 2021-12-31GeographyUnited States978,978,000USD0000950170-24-022233
    FY 2020Yearly · 2020-12-31GeographyCanada1,725,000USD0001564590-21-011526
    FY 2020Yearly · 2020-12-31GeographyOther Countries4,653,000USD0001564590-21-011526
    FY 2020Yearly · 2020-12-31GeographyUnited States415,334,000USD0001564590-21-011526
    FY 2019Yearly · 2019-12-31GeographyCanada2,245,000USD0001564590-21-011526
    FY 2019Yearly · 2019-12-31GeographyOther Countries5,269,000USD0001564590-21-011526
    FY 2019Yearly · 2019-12-31GeographyUnited States25,014,000USD0001564590-21-011526
    FY 2018Yearly · 2018-12-31GeographyCanada3,984,000USD0001564590-19-008991
    FY 2018Yearly · 2018-12-31GeographyChina109,000USD0001564590-19-008991
    FY 2018Yearly · 2018-12-31GeographyOther Countries4,679,000USD0001564590-19-008991
    FY 2018Yearly · 2018-12-31GeographyUnited States12,579,000USD0001564590-19-008991
    Q3 2018Quarterly · 2018-09-30ProductGenetic Testing Services5,625,000USD0001564590-18-028969
    Q3 2018Quarterly · 2018-09-30ProductRoyalty12,000USD0001564590-18-028969
    FY 2017Yearly · 2017-12-31GeographyCanada4,091,000USD0001564590-19-008991
    FY 2017Yearly · 2017-12-31GeographyChina2,614,000USD0001564590-19-008991
    FY 2017Yearly · 2017-12-31GeographyOther Countries3,001,000USD0001564590-19-008991
    FY 2017Yearly · 2017-12-31GeographyUnited States9,024,000USD0001564590-19-008991
    FY 2016Yearly · 2016-12-31GeographyCanada3,798,000USD0001564590-18-006239
    FY 2016Yearly · 2016-12-31GeographyChina3,241,000USD0001564590-18-006239
    FY 2016Yearly · 2016-12-31GeographyOther Countries2,979,000USD0001564590-18-006239
    FY 2016Yearly · 2016-12-31GeographyUnited States8,258,000USD0001564590-18-006239

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.